首页分享医疗健康领域知识图谱服务公司SeeMedX宣布任命Peter Ganz博士为顾问委员会成员

医疗健康领域知识图谱服务公司SeeMedX宣布任命Peter Ganz博士为顾问委员会成员

来源：花匠小妙招时间：2025-09-01 11:11

LAS VEGAS, June 18, 2024 /PRNewswire/ -- SeeMedX, Inc. ('SeeMedX') today announced the appointment of Dr. Peter Ganz to its advisory board, effective immediately. Dr. Ganz is a distinguished leader in cardiology and a pioneer in clinical cardiac research, including current work with precision medicine enabled by proteomics and machine learning..

拉斯维加斯，2024年6月18日/PRNewswire/--SeeMedX，Inc.（“SeeMedX”）今天宣布任命Peter Ganz博士为其顾问委员会成员，立即生效。Ganz博士是心脏病学领域杰出的领导者，也是临床心脏研究的先驱，包括目前通过蛋白质组学和机器学习实现的精准医学研究。。

'Dr. Ganz's extensive expertise and experience will be instrumental in guiding SeeMedX as we advance our innovative cardiac monitoring solutions,' said SeeMedX CEO, Deborah Simpson. 'Because of his standing in the cardiology community, his belief in the efficacy of SeeMedX's non-invasive hemodynamic monitoring system will be influential with cardiologists around the world.'.

'博士。SeeMedX首席执行官黛博拉·辛普森（DeborahSimpson）说，甘茨（Ganz）丰富的专业知识和经验将有助于指导SeeMedX推进创新的心脏监测解决方案由于他在心脏病学界的地位，他对SeeMedX无创血流动力学监测系统功效的信念将对世界各地的心脏病专家产生影响。”。

Dr. Ganz is Director of the Center of Excellence in Vascular Research at the Zuckerberg San Francisco General Hospital and is also a Professor of Medicine at the University of California, San Francisco ('UCSF'). Previously he served as the Chief of the Cardiovascular Division at Zuckerberg San Francisco General Hospital and the Maurice Eliaser Distinguished Professor of Medicine at UCSF from 2008 to 2019.

甘茨博士是扎克伯格旧金山总医院血管研究卓越中心主任，也是加州大学旧金山分校（UCSF）的医学教授。此前，他曾于2008年至2019年担任扎克伯格旧金山总医院心血管科科长和加州大学旧金山分校莫里斯·埃利泽杰出医学教授。

Prior to that time, Dr. Ganz spent 25 years directing cardiovascular research in the Cardiac Catheterization Laboratories at the Brigham and Women's Hospital and Harvard Medical School. Dr. Ganz has published extensively in prestigious medical journals and has received numerous recognitions for his contributions to cardiology..

在此之前，甘茨博士花了25年时间在布莱根妇女医院和哈佛医学院的心脏导管插入术实验室指导心血管研究。Ganz博士在著名的医学期刊上发表了大量文章，并因其对心脏病学的贡献而获得了众多认可。。

'In today's environment, doctors need access to technology like SeeMedX has developed,' said Dr. Ganz. 'Their non-invasive hemodynamic monitor can provide much needed information accurately, economically, safely, and rapidly. It has the potential to prevent hospitalizations for acute decompensated heart failure by diagnosing volume overload before it becomes clinically apparent.

甘茨博士说，在当今的环境下，医生需要获得SeeMedX开发的技术他们的无创血流动力学监护仪可以准确、经济、安全、快速地提供急需的信息。它有可能通过在临床上变得明显之前诊断容量超负荷来预防急性失代偿性心力衰竭的住院治疗。

I look forward to working with them to establish the use of the technology as a clinical standard in cardiology practices.'.

我期待着与他们合作，将该技术作为心脏病学实践中的临床标准。”。

About SeeMedXSeeMedX is dedicated to revolutionizing cardiac care through the development of advanced cardiac monitoring systems utilizing bioimpedance technology. Our mission is to provide healthcare professionals with accurate, real-time data to improve patient outcomes. For more information, visit www.seemedx.com..

关于SeeMedXSeeMedX致力于通过利用生物阻抗技术开发先进的心脏监测系统来彻底改变心脏护理。我们的使命是为医疗保健专业人员提供准确、实时的数据，以改善患者的预后。有关更多信息，请访问www.seemedx.com。。

For more information:Visit www.seemedx.comFollow us on LinkedIn

有关更多信息，请访问www.seemedx.com在LinkedIn上关注我们

SOURCE SeeMedX, Inc.

来源：SeeMedX，Inc。